Kalintis Healthcare Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LORAZEPAM USP, with a corresponding US DMF Number 35299.
Remarkably, this DMF maintains an Active status since its submission on December 11, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 29, 2021, and payment made on December 08, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II